Prostaglandin E1 reduces the risk of delayed graft function after cadaveric renal transplantation

Nephrol Dial Transplant. 1999:14 Suppl 4:32-3. doi: 10.1093/ndt/14.suppl_4.32.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Alprostadil / therapeutic use*
  • Cadaver
  • Female
  • Graft Survival / drug effects
  • Humans
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Pilot Projects
  • Risk

Substances

  • Alprostadil